NHS Bristol, North Somerset and South Gloucestershire CCG has signed a three-year contract with C the Signs, a diagnostic tool to help detect cancer at an early stage. The tool has been developed by NHS doctors and uses artificial intelligence technology to help to identify patients with suspected cancer, or who may be at risk of cancer.
The company said it “covers the entire spectrum of cancer, cross-referencing multiple diagnostic pathways, to support clinicians to identify what cancer or cancers a patient is at risk of”, and can also be used to support the “most appropriate next step for the patient; whether a test, investigation or urgent referral”.Through a £159,000 contract, NHS Bristol, North Somerset and South Gloucestershire CCG will now introduce the tool to its GP Practices.
The CCG said “the cancer specific tool is the only affordable solution, and is known to be able to meet the CCG’s urgent go-live requirements”. Key to the contract award is the ability for the system to integrate into EMIS, the GP clinical system used by practices in the area.
Last year, the tool was rolled out to 400 GP practices across Brent, Ealing, Hammersmith & Fulham, Harrow, Hillingdon, Hounslow, Kensington & Chelsea, and Westminster, to support GPs in monitoring and supporting patients who are at risk of cancer, aiming to make earlier identifications.
Bhavagaya Bakshi, GP and co-founder of C the Signs, commented: “one in two people will be diagnosed with cancer. Delays in accessing cancer care can mean life or death for patients; it is therefore vital for us to ensure all patients at risk of cancer are identified and referred urgently.
“Although behind the scenes, C the Signs has already made dramatic differences in patients’ lives by supporting doctors in this complex and challenging area of cancer. We are delighted to be rolling this out further so more patients can benefit.”